Secondary outcomes were: use of pharmacotherapy, adverse events and continuous abstinence up to 4 and 12 weeks.Ī total of 468 participants attended treatment (255 ACE versus 213 SSS, P < 0.05). Primary analysis was by intention to treat. The primary outcome was self-reported continuous abstinence for 26 weeks from the quit/quit re-set date verified by exhaled breath carbon monoxide measurement < 10 parts per million (p.p.m.). The comparator was a specialist stop smoking service (SSS) providing behavioural and pharmacological support in accordance with national standards. It aims to make it easy to stop smoking by convincing smokers that smoking provides no benefits for them. This centres on a 4.5-6-hour session of group-based support, alongside subsequent text messages and top-up sessions if needed. The intervention was the ACE method of stopping smoking.
Participant baseline characteristics (ethnicity, educational level, number of previous quit attempts, nicotine dependence) were evenly balanced between treatment groups. Mean age for the total sample was 40.8 years, with 53.4% being male. Adult (≥ 18 years) smokers wanting to quit were randomized in a 1 : 1 ratio. London, UK, between February 2017 and May 2018.Ī total of 620 participants (310 in ACE and 310 in the combined behavioural and pharmacological support condition) were included in the analysis. We compared the effectiveness of ACE with specialist behavioural and pharmacological support delivered to the national standard in England.Ī two-arm, parallel-group, single-blind, randomized controlled trial. Allen Carr's Easyway (ACE) is a single-session pharmacotherapy-free programme that has been in operation internationally for 38 years. Weight gain 3.8 kg in AC vs 1.8kg in Quit.ie (p value <0.05).Ĭonclusions All AC quit rates were superior to Quit.ie, outcomes were comparable with established interventions.Ī combination of behavioural and pharmacological support is judged to be the optimal approach for assisting smoking cessation. Results AC had higher quit rates at 1, 3, 6 and 12 months. Is an online portal for smoking cessation. AC consisted of a 5-hour seminar, in a group setting. Secondary aims: quit rates at 1, 6 and 12 months and analysis of associated factors including weight. Primary aim was to determine if AC had higher quit rates than Quit.ie service at 3 months. Block randomisation, enrolment and follow-up at 1, 3, 6 and 12 months. Intervention Randomly assigned to AC (n=151) and Quit.ie (n=149), matched for age, sex and education. outcomes for all 300 were analysed (intention-to-treat). Participants 300 adult smokers, 18 years plus, minimum 5 cigarettes daily, and English speaking.ĪC, 151 (females 44.4%) and Quit.ie, 149 (females 45.6%), mean age 44 years.
Setting Single centre, open RCT, general population based.
Objective To determine if Allen Carr’s Easyway to Stop Smoking (AC) was superior to Quit.ie in a randomised clinical trial (RCT).